Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash from operating activities:    
Net loss $ (2,143,683) $ (2,644,616)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 116,588 73,628
Stock based compensation 75,128 250,577
Stock issued for services 32,500 40,000
Amortization of operating lease right of use asset 77,101 77,636
Changes in assets and liabilities:    
Accounts receivable 2,700,917 1,449,908
Contract assets (1,000,590) (264,223)
Inventory (101,167) (24,426)
Prepaid expenses and other current assets 228,941 (264,687)
Accounts payable (1,008,207) (95,708)
Accrued expenses (85,371) (30,622)
Operating lease obligation (8,107) 70,094
Contract liabilities 1,108,864 534,706
Net cash used in operating activities (7,086) (827,733)
Cash flows from investing activities:    
Purchase of patents/trademarks (7,339) (600)
Purchase of software development (212,067)
Purchase of fixed assets (41,738) (101,478)
Net cash used in investing activities (261,144) (102,078)
Cash flows from financing activities:    
Repayments of insurance and equipment financing (201,485) (128,437)
Repayment of finance lease (11,285) (23,959)
Proceeds from common stock issued 6,095,000
Issuance cost (299,145) (576,650)
Proceeds from preferred stock issued 4,000,000
Net cash provided by financing activities 3,488,085 5,365,954
Net increase in cash 3,219,855 4,436,143
Cash, beginning of period 1,121,092 893,720
Cash, end of period 4,340,947 5,329,863
Supplemental Disclosure of Cash Flow Information:    
Interest paid 1,180 3,180
Taxes paid
Supplemental Non-Cash Investing and Financing Activities:    
Notes issued for financing of insurance premiums $ 320,004 $ 242,591